Detection of glioblastoma response to temozolomide combined with bevacizumab based on μMRI and μPET imaging reveals [18F]-fluoro-L-thymidine as an early and robust predictive marker for treatment efficacy.

Detection of glioblastoma response to temozolomide combined with bevacizumab based on μMRI and μPET imaging reveals [18F]-fluoro-L-thymidine as an early and robust predictive marker for treatment efficacy.

Item

http://www.wikidata.org/entity/Q36500372

Q36500372

about

Monitoring of anti-cancer treatment with (18)F-FDG and (18)F-FLT PET: a comprehensive review of pre-clinical studies Clinical applications of PET/MRI: current status and future perspectives.Potential influence of Gadolinium contrast on image segmentation in MR-based attenuation correction with Dixon sequences in whole-body 18F-FDG PET/MR.Neuroimaging of Peptide-based Vaccine Therapy in Pediatric Brain Tumors: Initial Experience.Quantitative multiparametric MRI assessment of glioma response to radiotherapy in a rat model FLT-PET for early response evaluation of colorectal cancer patients with liver metastases: a prospective study 18F-glutathione conjugate as a PET tracer for imaging tumors that overexpress L-PGDS enzyme.The impact of bevacizumab treatment on survival and quality of life in newly diagnosed glioblastoma patients.[(18)F]-fluoro-L-thymidine PET and advanced MRI for preoperative grading of gliomas.Investigation of brain tumors using (18)F-fluorobutyl ethacrynic amide and its metabolite with positron emission tomography Current status and future directions of anti-angiogenic therapy for gliomas A comparison of PET imaging agents for the assessment of therapy efficacy in a rodent model of glioma Update on bevacizumab and other angiogenesis inhibitors for brain cancer.99mTc-Tetrofosmin Uptake Correlates with the Sensitivity of Glioblastoma Cell Lines to Temozolomide.Multimodal imaging based on MRI and PET reveals [(18)F]FLT PET as a specific and early indicator of treatment efficacy in a preclinical model of recurrent glioblastoma.Bevacizumab in recurrent glioblastoma: open issues.Temozolomide arrests glioma growth and normalizes intratumoral extracellular pH.Positron emission tomography imaging in gliomas: applications in clinical diagnosis, for assessment of prognosis and of treatment effects, and for detection of recurrences.Players of 'hypoxia orchestra' - what is the role of FMISO?[F]Fludarabine-PET as a promising tool for differentiating CNS lymphoma and glioblastoma: Comparative analysis with [F]FDG in human xenograft models

P2860

Q26778463-54815419-765F-48E4-A87B-998885F1ABBE Q30835897-8471400C-6011-4E86-9125-C44F6101249D Q31032111-F56DB351-9A64-43A9-9B61-F7C1B7AD2563 Q31144824-472A1C9F-6D4C-425E-AC7D-C39F301B690A Q33616603-42B71625-7BBA-46E3-81BE-E0D71716CF9B Q33889809-A99594F2-C140-486D-B240-A53C43B4D013 Q34027558-DDC4909F-EC25-4B05-8F29-A9D8D5201506 Q34293163-1EE5AE5C-12A3-49DA-A6F8-A41139E90DBC Q35760788-428A3C5D-E9A3-40E0-B6A0-49A13DFB08FE Q35907186-A71CCE73-0DA1-4938-96C8-BA8B74BBE3F6 Q36618235-63621370-553E-4E3F-AFA6-CA83EEA9E859 Q37201450-BF6E54E0-67BC-4C37-AC22-5511D70B544F Q38106370-BE08AD6F-E2AC-4CC3-AB6C-95A1C5A0E4C5 Q38715704-83B2632C-B599-4C30-8F87-7B681146CB2B Q38822001-2B8B7EF8-F3D4-4698-97D4-02E5383905E0 Q38965301-776949D1-5FD4-40E0-B903-E650CD08A524 Q41367767-424D948A-4927-4D1A-8189-AF9BC0FEDE16 Q48158155-A61AC6D5-585A-47D3-A979-89508D74E923 Q52939507-E65DC31A-7E4E-44EC-8E1F-3701B00B9F5E Q58788935-E540F37B-4664-4460-945E-18924019DF5E

P2860

Detection of glioblastoma response to temozolomide combined with bevacizumab based on μMRI and μPET imaging reveals [18F]-fluoro-L-thymidine as an early and robust predictive marker for treatment efficacy.

Item

http://www.wikidata.org/entity/Q36500372

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Detection of glioblastoma resp ...... marker for treatment efficacy.

@ast

Detection of glioblastoma resp ...... marker for treatment efficacy.

@en

type

Item

label

Detection of glioblastoma resp ...... marker for treatment efficacy.

@ast

Detection of glioblastoma resp ...... marker for treatment efficacy.

@en

prefLabel

Detection of glioblastoma resp ...... marker for treatment efficacy.

@ast

Detection of glioblastoma resp ...... marker for treatment efficacy.

@en

P1476

Detection of glioblastoma resp ...... marker for treatment efficacy.

@en

P2093

Andréas H Jacobs

http://www.w3.org/2001/XMLSchema#string

Aurélien Corroyer-Dulmont

http://www.w3.org/2001/XMLSchema#string

Didier Divoux

http://www.w3.org/2001/XMLSchema#string

Edwige Petit

http://www.w3.org/2001/XMLSchema#string

Jean-Sébastien Guillamo

http://www.w3.org/2001/XMLSchema#string

Jérôme Delamare

http://www.w3.org/2001/XMLSchema#string

Jérôme Toutain

http://www.w3.org/2001/XMLSchema#string

Louisa Barré

http://www.w3.org/2001/XMLSchema#string

Myriam Lecocq

http://www.w3.org/2001/XMLSchema#string

Méziane Ibazizène

http://www.w3.org/2001/XMLSchema#string

P2860

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

Early detection of response to experimental chemotherapeutic Top216 with [18F]FLT and [18F]FDG PET in human ovary cancer xenografts in mice

Bevacizumab and daily temozolomide for recurrent glioblastoma.

Pseudoprogression and pseudoresponse: challenges in brain tumor imaging.

Advanced MRI and PET imaging for assessment of treatment response in patients with gliomas.

Advances in MRI assessment of gliomas and response to anti-VEGF therapy.

Assessment of multiparametric MRI in a human glioma model to monitor cytotoxic and anti-angiogenic drug effects

Intratumor heterogeneity characterized by textural features on baseline 18F-FDG PET images predicts response to concomitant radiochemotherapy in esophageal cancer

The paradoxical effect of bevacizumab in the therapy of malignant gliomas.

Anti-VEGF treatment reduces blood supply and increases tumor cell invasion in glioblastoma

P304

41-56

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/NEUONC/NOS260

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2012-10-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23115160

http://www.w3.org/2001/XMLSchema#string

P921

bevacizumab

P932

3534417

http://www.w3.org/2001/XMLSchema#string

Detection of glioblastoma response to temozolomide combined with bevacizumab based on μMRI and μPET imaging reveals [18F]-fluoro-L-thymidine as an early and robust predictive marker for treatment efficacy.

about

P2860

P2860

Detection of glioblastoma response to temozolomide combined with bevacizumab based on μMRI and μPET imaging reveals [18F]-fluoro-L-thymidine as an early and robust predictive marker for treatment efficacy.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932